Application 210309

Type
ANDA
Sponsor
GLENMARK PHARMS

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001DIMETHYL FUMARATEDIMETHYL FUMARATECAPSULE, DELAYED RELEASE;ORAL120MGNoNo
002DIMETHYL FUMARATEDIMETHYL FUMARATECAPSULE, DELAYED RELEASE;ORAL240MGNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
68462-307DIMETHYL FUMARATEdimethyl-fumarateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-307DIMETHYL FUMARATEdimethyl-fumarateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-307DIMETHYL FUMARATEdimethyl-fumarateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-307DIMETHYL FUMARATEdimethyl-fumarateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-308DIMETHYL FUMARATEdimethyl-fumarateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-308DIMETHYL FUMARATEdimethyl-fumarateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-308DIMETHYL FUMARATEdimethyl-fumarateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-308DIMETHYL FUMARATEdimethyl-fumarateGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-570DIMETHYL FUMARATEdimethyl fumarate kitGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-570DIMETHYL FUMARATEdimethyl fumarate kitGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-570DIMETHYL FUMARATEdimethyl fumarate kitGlenmark Pharmaceuticals Inc., USAANDACurrent
68462-570DIMETHYL FUMARATEdimethyl fumarate kitGlenmark Pharmaceuticals Inc., USAANDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
61120ORIG2019-12-03